PCVX
Vaxcyte, Inc. · Healthcare
Director Heath Lukatch sold $829K of Vaxcyte, Inc.
Sold$828,915
$63.76Price
13,000Shares
−70%Stake
What PCVX did after the filing
- The stock from Thu, Jan 4 close, $64.34
- +17.0%
- S&P 500, same days
- +6.9%
Measured over 30 trading days, to the Feb 16 close.
Traded Tue, Jan 2. Filed Thu, Jan 4, 11:26 AM ET, during the session. Returns use the Jan 4 close and the Feb 16 close. Not investment advice.